An interventional efficacy and safety, phase 2/3 double-blind, 2-arm study to investigate orally administered PF-07321332/Ritonavir compared with placebo in nonhospitalized symptomatic adult participants with COVID-19 who are at low risk of progressing to severe illness

Objective

Clinical Trial Details>>

Principal Investigator(s)
Jawad Nazir, MD

Clinical Trial Categories

  • COVID-19
  • Adult
  • Infectious Disease
Sponsor(s)
Pfizer
Contact
Avera Research Institute at 605-504-3154
or ARI@Avera.org

Location

  • Avera Medical Group Infectious Disease Specialists
    6709 S Minnesota Avenue
    Suite 102
    Sioux Falls, SD 57108
    Main: 605-322-7250
  • Avera Research Institute — Sioux Falls
    6001 S Sharon Ave
    Sioux Falls, SD 57108
    Main: 605-504-3154